about
Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and LipidomicsImmune cell screening of a nanoparticle library improves atherosclerosis therapyNanodiscs as a Modular Platform for Multimodal MR-Optical ImagingBiocompatibility of ferritin-based nanoparticles as targeted MRI contrast agents.Imaging of atherosclerosisBiomimetic high density lipoprotein nanoparticles for nucleic acid delivery.Single step reconstitution of multifunctional high-density lipoprotein-derived nanomaterials using microfluidics.Paramagnetic liposomes for molecular MRI and MRI-guided drug delivery.Utilizing imaging tools in lipidology: examining the potential of MRI for monitoring cholesterol therapy.Accumulation of nano-sized particles in a murine model of angiogenesis.Molecular magnetic resonance imaging of atherosclerotic vessel wall disease.Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging.Regression of Atherosclerosis: The Journey From the Liver to the Plaque and BackA facile method for isolation of recombinant human apolipoprotein A-I from E. coli.Recombinant lipoproteins reinforce cytotoxicity of doxorubicin to hepatocellular carcinoma.Core hydrophobicity tuning of a self-assembled particle results in efficient lipid reduction and favorable organ distribution.
P2860
Q26774903-8E13DD39-97E8-4B22-ABDF-0CA85DF33A02Q28393434-5A1D13F7-0485-4AAB-B07C-B37A16C00858Q28397423-DD867438-572C-4D50-8F70-BEDF9D038EA1Q30276990-A2F0FC62-59F1-476E-A587-2EE2F89A4DD3Q33697215-EA67C0A9-7A99-4325-862A-89E8A694DB02Q33830955-2476806D-1BBD-40CF-92DE-12E1E7F4FE36Q33924365-E0EC80FD-F989-44D3-869C-2F2CB93A348AQ34736942-9612B74D-9E5B-4290-A362-A1299D8D1EEAQ36422755-E640C10E-8393-4164-9CC2-95B87D0BCD91Q37540993-B862F380-A574-4B27-93DF-8712A7EA7CFCQ38542308-9D2FD4B4-81C0-4052-8B6B-99F500DB1B22Q38548184-C07F9AB7-C020-4F3A-8F54-113FA1BCB7BDQ38560870-6C5EE242-A1C5-4BCF-95F7-47EF4FF89C24Q38710948-0C926C88-6FB2-4FFC-8EDC-F7B8D6655631Q39086982-60AAD78A-3E89-4C7C-B446-95D507F611DBQ50018257-5A7EB1CE-AC5F-403E-9A22-0CD6657E553D
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
HDL as a contrast agent for medical imaging.
@en
HDL as a contrast agent for medical imaging.
@nl
type
label
HDL as a contrast agent for medical imaging.
@en
HDL as a contrast agent for medical imaging.
@nl
prefLabel
HDL as a contrast agent for medical imaging.
@en
HDL as a contrast agent for medical imaging.
@nl
P2093
P2860
P50
P356
P1433
P1476
HDL as a contrast agent for medical imaging.
@en
P2093
Alessandra Barazza
Torjus Skajaa
Willem Jm Mulder
Yanqing Ma
Zahi A Fayad
P2860
P304
P356
10.2217/CLP.09.38
P577
2009-08-01T00:00:00Z